Therefore, the question remains whether the ability of parthenolide and costunolide to reduce stable, detyrosinated tubulin in metastatic breast cancer cells occurs through a mechanism that is dependent or independent of their NF-κB inhibitory properties. Here, NFKB1 is linked to breast cancer.